Profound Medical
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,211 | $2,621 | $3,705 | $2,832 |
Gross Profit | 1,618 | 1,853 | 2,524 | 1,806 |
EBITDA | -13,665 | -11,003 | -8,683 | -9,046 |
EBIT | -13,806 | -11,166 | -8,759 | -9,261 |
Net Income | -15,695 | -10,724 | -5,334 | -9,365 |
Net Change In Cash | 2,211 | 2,621 | 3,705 | 2,832 |
Free Cash Flow | -13,744 | -8,283 | -5,642 | -6,826 |
Cash | 35,195 | 46,433 | 54,912 | 27,123 |
Basic Shares | 30,053 | 30,041 | 25,770 | 24,642 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,680 | $7,199 | $6,681 | $6,873 |
Gross Profit | 7,037 | 4,382 | 3,021 | 2,952 |
EBITDA | -33,062 | -26,781 | -25,549 | -28,648 |
EBIT | -33,953 | -27,927 | -27,638 | -31,003 |
Net Income | -26,480 | -28,569 | -28,669 | -30,699 |
Net Change In Cash | 10,680 | 7,199 | 6,681 | 6,873 |
Free Cash Flow | -23,453 | -22,609 | -25,800 | -22,953 |
Cash | 54,912 | 26,213 | 46,517 | 67,152 |
Basic Shares | 24,765 | 21,182 | 20,829 | 20,466 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.52 |
2025-03-31 | -$0.36 |
2024-12-31 | -$0.20 |
